The start date isn't a question: 07/26/2012 - a market exclusivity trigger date tied to the ability to actually market the drug is logical and in accordance with the law and clear congressional intent.
Investor suit v. Amarin - agree, will be dismissed.
AMRN vs ANDA (patents case): I hope ANDAs won't request the dismissal after positive NCE judgement and the case will continue.
Market Data 
Markets 
AI
